Protein biomarker discovery can help bridge the gap between genomes and phenotypes, allowing improved understanding of real-time human biology and a stronger grasp of the transition from health to disease. Performed by industry experts with specialization in proteomics, Discovery Life Sciences offers customizable proteomic services enabling a comprehensive understanding of the proteome and accelerating drug and diagnostic development programs.
Targeted and untargeted mass spectrometry with a wide range of workflow options
Robust immunoassays that deliver unmatched coverage and reproducibility
Deep unbiased proteogenomics through integration of proteomic and genomic services
Integrated NGS, cell biology, and pathology services with expert bioinformatic support
Our goal is to propel proteomics over the threshold to full adoption in the drug discovery pipeline. We deliver actionable biomarker data integrated with our existing genomics, IHC, and flow cytometry services to better meet our clients’ needs and help guide their precision programs.
EVP, Proteomics, Discovery Life Sciences
Single strategic partner for biospecimens and biomarker discovery
Over 10 Million
Over 20 Years of
Cell & Gene Therapy
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!